Alessio Cirillo

409 total citations
22 papers, 218 citations indexed

About

Alessio Cirillo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Alessio Cirillo has authored 22 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Otorhinolaryngology. Recurrent topics in Alessio Cirillo's work include Cancer Immunotherapy and Biomarkers (16 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Alessio Cirillo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Alessio Cirillo collaborates with scholars based in Italy, Ireland and India. Alessio Cirillo's co-authors include Andrea Botticelli, Bruna Cerbelli, Paolo Marchetti, Simone Scagnoli, Silvia Mezi, Ilaria Grazia Zizzari, Marianna Nuti, Lidia Strigari, Giulia Pomati and Antonella Polimeni and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Alessio Cirillo

19 papers receiving 216 citations

Peers

Alessio Cirillo
Wenxiao Dai China
Stephanie The United States
Diane Evrard France
Diana Shinko Australia
Karl Metzger Germany
Susanna Nguy United States
Liming Zhang China
Anna Gurevich‐Shapiro Israel
Shlomit Jessel United States
Junlong Xu China
Wenxiao Dai China
Alessio Cirillo
Citations per year, relative to Alessio Cirillo Alessio Cirillo (= 1×) peers Wenxiao Dai

Countries citing papers authored by Alessio Cirillo

Since Specialization
Citations

This map shows the geographic impact of Alessio Cirillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Cirillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Cirillo more than expected).

Fields of papers citing papers by Alessio Cirillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Cirillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Cirillo. The network helps show where Alessio Cirillo may publish in the future.

Co-authorship network of co-authors of Alessio Cirillo

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Cirillo. A scholar is included among the top collaborators of Alessio Cirillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Cirillo. Alessio Cirillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cirillo, Alessio, Lidia Strigari, Angelica Pace, et al.. (2025). Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients. Journal of Experimental & Clinical Cancer Research. 44(1). 316–316.
2.
Botticelli, Andrea, Martina Leopizzi, Alessio Cirillo, et al.. (2025). Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond. Pathologica. 117(2). 73–83. 1 indexed citations
3.
Botticelli, Andrea, Alessio Cirillo, Giulia d’Amati, et al.. (2024). The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients. Pathology - Research and Practice. 260. 155415–155415. 2 indexed citations
4.
Cirillo, Alessio, Daniele Marinelli, Umberto Romeo, et al.. (2024). Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis. BMC Cancer. 24(1). 430–430. 4 indexed citations
5.
6.
Ceccarelli, Fulvia, Francesco Natalucci, Alessio Cirillo, et al.. (2024). Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort. Clinical and Experimental Medicine. 24(1). 72–72.
7.
Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, et al.. (2023). Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 24(8). 7114–7114. 9 indexed citations
8.
Ceccarelli, Fulvia, Francesco Natalucci, G. Olivieri, et al.. (2023). Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study. Life. 13(4). 877–877. 7 indexed citations
9.
Nelli, Fabrizio, Agnese Fabbri, Andrea Botticelli, et al.. (2023). Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study. Frontiers in Oncology. 13. 1280416–1280416. 1 indexed citations
10.
Brauner, Edoardo, Valentino Valentini, Umberto Romeo, et al.. (2022). Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up. Diagnostics. 12(8). 1863–1863.
11.
Botticelli, Andrea, Agnese Fabbri, Michela Roberto, et al.. (2022). The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature. Frontiers in Oncology. 12. 797157–797157. 2 indexed citations
12.
Botticelli, Andrea, Giulia Pomati, Alessio Cirillo, et al.. (2022). The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. Frontiers in Immunology. 13. 974087–974087. 12 indexed citations
13.
Botticelli, Andrea, Alessio Cirillo, Bruna Cerbelli, et al.. (2022). Suppressive immune profile in combined positive score positive head and neck cancer patients treated with immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). e18014–e18014. 1 indexed citations
14.
Trevisani, Francesco, Federico Di Marco, Matteo Floris, et al.. (2022). Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario. Vaccines. 10(5). 679–679. 9 indexed citations
15.
Botticelli, Andrea, Alessio Cirillo, Lidia Strigari, et al.. (2021). Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis. Frontiers in Immunology. 12. 705096–705096. 67 indexed citations
16.
Botticelli, Andrea, Alessio Cirillo, Giulia Pomati, et al.. (2021). The role of opioids in cancer response to immunotherapy. Journal of Translational Medicine. 19(1). 119–119. 29 indexed citations
17.
Botticelli, Andrea, Ilaria Grazia Zizzari, Simone Scagnoli, et al.. (2021). The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study. Journal of Personalized Medicine. 11(7). 651–651. 41 indexed citations
18.
Botticelli, Andrea, Silvia Mezi, Giulia Pomati, et al.. (2020). The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial. Vaccines. 8(2). 191–191. 9 indexed citations
19.
Mezi, Silvia, Giulia Pomati, Andrea Botticelli, et al.. (2020). Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience. Anti-Cancer Drugs. 31(10). 1074–1083. 1 indexed citations
20.
Ciatto, Stefano, et al.. (1996). Tamoxifen as primary treatment of breast cancer in elderly patients.. PubMed. 43(1). 43–5. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxiao Dai Breakdown of academic impact, for papers by Stephanie The Breakdown of academic impact, for papers by Diane Evrard Breakdown of academic impact, for papers by Diana Shinko Breakdown of academic impact, for papers by Karl Metzger Breakdown of academic impact, for papers by Susanna Nguy Breakdown of academic impact, for papers by Liming Zhang Breakdown of academic impact, for papers by Anna Gurevich‐Shapiro Breakdown of academic impact, for papers by Shlomit Jessel Breakdown of academic impact, for papers by Junlong Xu
Rankless by CCL
2026